Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF/JAK2/STAT3 axis

• Asıl Yazarlar: Hongmei Zhang (Yazar), Chunling Liu (Yazar), Ye Jin (Yazar), Zheng Wang (Yazar), Yi Guan (Yazar), Zhenxian Jia (Yazar), Tong Cui (Yazar), Zhi Zhang (Yazar), Xuemei Zhang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundAnlotinib, a highly selective inhibitor of VEGFR2, has demonstrated significant anti-tumor effects in various cancers. However, its potential synergistic effects with DDP (cisplatin) in breast cancer (BRCA) remain to be fully elucidated. This study aims to discover the therapeutic efficacy...